Healthcare -
Biotechnology - NASDAQ - US
$ 8.195
-1.62 %
$ 1.32 B
Market Cap
-3.76
P/E
NVAX - OPERATING EXPENSES
Operating Expenses NVAX - Novavax, Inc.
779 M
LAST VALUE
-47.56%
2 YEAR CAGR
30.20%
5 YEAR CAGR
28.17%
10 YEAR CAGR